Enhancement of Antitumor Activity of Herpes Simplex Virus Γ134.5-Deficient Mutant for Oral Squamous Cell Carcinoma Cells by Hexamethylene Bisacetamide
Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700957
Full Text
Open PDFAbstract
Available in full text
Date
April 28, 2006
Authors
Publisher
Springer Science and Business Media LLC